38mon MSN
Indian Scientists Create Protein That Lights Up During Gene Editing, May Aid Cancer Treatment
Scientists from Kolkata-based Bose Institute have created GlowCas9--a CRISPR protein that lights up while performing gene ...
Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...
Hosted on MSN
New Method for Discovering Antibiotics from Bacteria
Numerous natural products produced by microorganisms can be utilized as active ingredients to treat illnesses like cancer and infections. Although the microbes' genes contain the blueprints for these ...
In cooperation with universities, the Center of Estonian Rural Research and Knowledge (METK) is leading a project aimed at ...
A team of researchers at the Icahn School of Medicine at Mount Sinai has uncovered why children with the same ...
News Medical on MSN
Leukemia That Starts Before Birth Is More Aggressive
A Mount Sinai team showed that the same leukemia mutation behaves differently depending on when it arises during development.
Sofi-cel is an investigational, potential first-in-class, allogeneic, anti-CD7 CAR-T cell therapy currently under evaluation in a pivotal trial (T-RRex) for patients with relapsed or refractory (R/R) ...
MedPage Today on MSN
Gene Therapy Also Effective in Younger Children With Inherited Blood Disorders
Exa-cel is the first FDA-approved therapy utilizing CRISPR/Cas9, a type of gene editing technology through which patients' ...
Penn Medicine shows how sustained research investment drives innovation, economic growth, and global health breakthroughs.
Dyadic International, Inc. ( DYAI) IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 December 9, 2025 9:30 AM EST Good day, and welcome to the iAcessAlpha Virtual Best Ideas winter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback